DWM
RDY icon

Doyle Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Doyle Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,000
Closed -$15K – 620
2019
Q2 		$15K Buy
+2,000
New +$15.7K ﹤0.01% 562
2019
Q1 		– Sell
-2,000
Closed -$15K – 606
2018
Q4 		$15K Buy
+2,000
New +$14.1K ﹤0.01% 562

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Doyle Wealth Management's RDY Position: Q3 2019 in Review

Doyle Wealth Management sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 2,000 shares — an estimated $15K sold.

Doyle Wealth Management first reported a position in RDY in Q4 2018 and held it in 2 quarters. The position peaked at $15K in Q2 2019. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

  • Doyle Wealth Management reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
  • Doyle Wealth Management sold 2,000 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $15K.
  • Doyle Wealth Management first reported a position in Dr. Reddy's Laboratories in Q4 2018 and held it in 2 quarters.
  • Doyle Wealth Management's Dr. Reddy's Laboratories position peaked at $15K in Q2 2019.
  • 152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on Doyle Wealth Management's 13F filing for Q3 2019, filed 5 Nov 2019.